Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization

Eur Heart J. 2020 May 1;41(17):1633-1635. doi: 10.1093/eurheartj/ehz912.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Myocardial Infarction* / therapy
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Secondary Prevention
  • Ticagrelor

Substances

  • Platelet Aggregation Inhibitors
  • Ticagrelor